This Article Full Text Full Text (PDF) All Versions of this Article: 37/2/393    most recent 01.STR.0000198878.66000.4ev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kuroda, S. Articles by Iwasaki, Y. Search for Related Content PubMed PubMed Citation Articles by Kuroda, S. Articles by Iwasaki, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB OXYGEN

(Stroke. 2006;37:393.)
© 2006 American Heart Association, Inc.

Original Contributions

Cerebral Oxygen Metabolism and Neuronal Integrity in Patients With Impaired Vasoreactivity Attributable to Occlusive Carotid Artery Disease

Satoshi Kuroda, MD, PhD; Tohru Shiga, MD, PhD; Kiyohiro Houkin, MD, PhD; Tatsuya Ishikawa, MD, PhD; Chietsugu Katoh, MD, PhD; Nagara Tamaki, MD, PhD Yoshinobu Iwasaki, MD, PhD

From the Departments of Neurosurgery (S.K., T.I., Y.I.) and Nuclear Medicine (T.S., C.K., N.T.), Hokkaido University Graduate School of Medicine, Japan; and Department of Neurosurgery (K.H.), Sapporo Medical University, Japan.

Correspondence to Satoshi Kuroda, MD, PhD, Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo 060-8638, Japan. E-mail skuroda{at}med.hokudai.ac.jp

Background and Purpose— It is still unclear that impaired cerebrovascular reactivity (CVR) to acetazolamide is comparable to elevated oxygen extraction fraction (OEF) on positron emission tomography (PET) in patients with occlusive carotid diseases. Therefore, in this study, the authors aimed to clarify whether OEF is elevated in all patients with reduced cerebral blood flow (CBF) and CVR (type 3) on single photon emission computed tomography (SPECT), and, if not, to specify the underlying pathophysiology of type 3 but normal OEF.

Methods— This study included 46 patients who had decreased CBF and CVR on N-isopropyl-p-¹²³I-iodoamphetamine SPECT in the ipsilateral middle cerebral artery area attributable to occlusive carotid diseases. Hemodynamic and metabolism parameters were determined in all patients by ¹⁵O-gas PET, and neuronal integrity was evaluated in 19 patients using ¹¹C-flumazenil (FMZ) PET.

Results— OEF was significantly elevated in 20 (43.5%) of 46 type 3 patients. Another 26 type 3 patients had normal OEF. Regression analysis showed that OEF significantly correlated with cerebral metabolic rate for oxygen and ¹¹C-FMZ binding potential but not with other parameters. Subcortical infarction had no significant effect on OEF values.

Conclusions— The results strongly suggest that type 3 patients with reduced CBF and CVR may be divided into 2 pathophysiologically different subgroups: misery perfusion attributable to hemodynamic compromise and matched hypometabolism attributable to incomplete infarction. Type 3 but normal OEF may represent a transition stage from misery perfusion to matched hypometabolism.

Key Words: acetazolamide • cerebral ischemia • flumazenil • metabolism • oxygen